Sharapova vows to 'rise up again' after French Open snub

Sharapova can rise above the furore surrounding her return if she accepts the decision to deny her a wild card entry to the French Open without rancor, former world No. 3 Pam Shriver has said.

"While it's true that the CAS has reduced her sanction, it is still a violation of the tennis anti-doping program", Giudicelli said.

"I read the results of several polls and I could see that about two-thirds were in favor of Maria being granted a wild card".

"I definitely felt a little bit better".

Let's start by making one thing clear: Maria Sharapova is not a drugs cheat.

It must have been especially hard for Giudicelli and Forget to use the example of a player who has lifted the Coupe Suzanne Lenglen twice, won five grand slam titles and was world No 1. "They might be disappointed, she might be very disappointed".

"It is not for me to question that (CAS) decision". But nevertheless Roland Garros invests a lot - along with the other Grand Slams, the ATP, and the WTA - into the fight against doping.

Some of Sharapova's rivals have openly criticised her return.

"I know the media dimension Maria has".

The two-time French Open champion took to Twitter yesterday to shed light on her thoughts about the wildcard snub.

She is now ranked 211th, not good enough to make the cut even for the qualifying field at Roland Garros.

The Russian issued a statement afterwards that failed to address the French Open and said merely that she hoped her injury "is not serious".

Sharapova, a five-time Grand Slam victor, made her return to competition in April at the Stuttgart Open in April after a 15-month ban over a positive test for the angina drug meldonium.

Sharapova was initially handed a two-year ban after testing positive for banned substance meldonium during the 2016 Australian Open.

"Must be tough for her, but it's the way it is", Novak Djokovic said after he overcame a challenging first set to beat British qualifier Aljaz Bedene 7-6 (2), 6-2 in his opening match at the Foro Italico.

"What I do not agree with is the basis put forward by the FFT for their decision with respect to Maria Sharapova".

Wimbledon chiefs have until 20 June - 13 days before the tournament begins - to decide whether to hand Sharapova a wild card, although she may have another route via the qualifying competition.

Sharapova had stunned the tennis world when she announced previous year that she had tested positive for heart drug meldonium at the Australian Open after failing to realise it had been added to WADA's list of banned substances. She was a past champion at all three.

In Stuttgart, WTA CEO Steve Simon told German broadcaster ZDF she had paid the price.

"I don't think a suspension should wipe out the career's worth of work", Simon said.

Vanessa Coleman